Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 51 results for "Zohydro"

Recent Research Analysts Ratings Updates for Pernix Therapeutics Holdings (PTX)
American Banking News - Forex

Recent Research Analysts Ratings Updates for Pernix Therapeuti...

Pernix Therapeutics Holdings (NYSE: PTX) has recently received a number of price target changes and ratings updates: 8/10/2015 Pernix Therapeutics Holdings had its price target lowered by analysts at Brean Capital from $17.00 to $14.00. They now ... American Banking News - Forex, 1 week ago

Express Scripts stiff-arms AZ's Onglyza, Vivus' Qsymia with new 2016 formulary

Express Scripts ($ESRX) has passed judgment for 2016. Almost 20 new meds, including some closely watched products like Vivus' ($VVUS) weight loss med Qsymia, won't be covered on the pharmacy benefits manager's 2016 preferred formulary. The ...
 FiercePharma3 weeks ago

Zogenix Upgraded at Zacks (ZGNX)

Zacks upgraded shares of Zogenix (NASDAQ:ZGNX) from a sell rating to a hold ratingin a resaerch note published onFriday, AnalystRatings.NET reports. According to Zacks, Zogenix, Inc. is a pharmaceutical company engaged in the development and ...
 WKRB News3 weeks ago Zogenix Rating Increased to Hold at Zacks (ZGNX)  SleekMoney3 weeks ago Zogenix Downgraded by Zacks to Sell (ZGNX)  SleekMoney1 month ago Zogenix Receives $2.80 Average Target Price from Analysts (NASDAQ:ZGNX)  SleekMoney1 month ago

Oppenheimer Reiterates Outperform Rating for Pernix Therapeutics Holdings (PTX)

Pernix Therapeutics Holdings (NYSE:PTX) s stock had its outperform rating reaffirmed by analysts at Oppenheimer in a research report issued to clients and investors on Tuesday, MarketBeat.Com reports. They currently have a $13.00 price objective on ...
 WKRB News4 weeks ago Pernix Therapeutics Holdings Receives Outperform Rating from Oppenheimer (PTX)  SleekMoney4 weeks ago

ALKERMES PLC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our condensed consolidated financial statements and related notes beginning on page 5 of this Form 10-Q, and Management's Discussion and Analysis of Financial Condition and Results of ...
 Pharmacy Choice4 weeks ago

Pre-Market Activity Shows Heavy Volume And Movement For Zogenix (ZGNX)

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Zogenix ( ...
 TheStreet.com4 weeks ago Today's Weak On High Volume Stock: Zogenix (ZGNX)  TheStreet.com1 month ago Zogenix (ZGNX) Flagged As Strong On High Volume  TheStreet.com2 months ago

Pernix Releases Positive in vitro Abuse Deterrent Data for Third Generation Extended Release Hydrocodone ZX007

(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc . ( NASDAQ:PTX ), a specialty pharmaceutical company, today announced positive results from Category 1 (in vitro) abuse deterrence studies with ZX007, utilizing Altus Formulation's proprietary ...
 Franklin Credit Management Corporation1 month ago Pernix Therapeutics : Releases Positive in vitro Abuse Deterrent Data for Third Generation Extended Release Hydrocodone ZX007  4 Traders1 month ago Pernix (PTX) Releases Positive In Vitro Abuse Deterrent Data For Third Generation Extended Release Hydrocodone ZX007 7/27/2015  ClinicSpace1 month ago
[x]  
SleekMoney

Investment Analysts Updated EPS Estimates for July, 28th (ACC, AEGR, AIXG, ALSN, AVB, BLCM, BSY, CAVM, CCI, CKEC)

Investment Analysts updated eps estimates for Tuesday, July 28th: American Campus Communities (NYSE:ACC) had its hold rating reaffirmed by analysts at MLV & Co.. MLV & Co. currently has a $42.00 target price on the stock. Aegerion ...
 SleekMoney1 month ago
Seeking Alpha

Zogenix: Promising Small Cap Biotech Is Breaking Out

Jul. 15, 2015 10:04 AM ET | About: Zogenix, Inc. (ZGNX), Includes: PTX by: Summary Zogenix has been on the move since it did a reverse 8 to 1 stock split. The company made a game changing move by selling its core drug product to invest in ...
 Seeking Alpha1 month ago This Week In Pharma: Controversies And Revelations About Synergy And Zogenix  Seeking Alpha2 months ago

Brean Capital bullish on Zogenix; PT raised to $28

Brean Capital raises it price target for Zogenix (NASDAQ:ZGNX) to $28 (58% upside), citing the potential of its two lead product candidates, ZX008 for Dravet syndrome and Relday (risperidone) for schizophrenia. Phase 3 trials for Orphan ...
 Seeking Alpha1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less